http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006002077-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_524751ffbe627c686308613658d15573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0033c917c770974232573e8e0dcd24c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca08c97bc97c34f17af7b28505d4765d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef452377f3aa38792917272c1e6c4a36
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2005-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436a771a8bd39062450b9e469fc949ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bba615dcc59e3837bafdc0ce9801fab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dc943c46fc0b4544ea052782d629335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798a5dc1880acdf773a60f934e3dc922
publicationDate 2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006002077-A3
titleOfInvention Stable pharmaceutical formulations of benzimidazole compounds
abstract Provided are stable pharmaceutical formulations of benzimidazole compounds, particularly esomeprazole magnesium, and processes for their preparation.
priorityDate 2004-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9601622-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5817338-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4786505-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6328994-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16413917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450426460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9820678

Total number of triples: 46.